会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明授权
    • Method for enhancing production of isoprenoid compounds
    • 增强异戊二烯化合物生产的方法
    • US07670825B2
    • 2010-03-02
    • US11624094
    • 2007-01-17
    • Jay D. KeaslingJack D. NewmanDouglas J. Pitera
    • Jay D. KeaslingJack D. NewmanDouglas J. Pitera
    • C12N1/20C12N15/74C12N15/87C12P5/02C12P21/06C12P13/00A01N43/04
    • C12P23/00C12N9/0006C12P9/00
    • The present invention provides methods of producing an isoprenoid or an isoprenoid precursor in a genetically modified host cell. The methods generally involve modulating the level of hydroxymethylglutaryl-CoA (HMG-CoA) in the cell, such that the level of HMG-CoA is not toxic to the cell and/or does not substantially inhibit cell growth, but is maintained at a level that provides for high-level production of mevalonate, IPP, and other downstream products of an isoprenoid or isoprenoid pathway, e.g., polyprenyl diphosphates and isoprenoid compounds. The present invention further provides genetically modified host cells that are suitable for use in a subject method. The present invention further provides recombinant nucleic acid constructs for use in generating a subject genetically modified host cell, including recombinant nucleic acid constructs comprising nucleotide sequences encoding one or more mevalonate pathway enzymes, and recombinant vectors (e.g., recombinant expression vectors) comprising same. The present invention further provides methods for identifying nucleic acids that encode HMG-CoA reductase (HMGR) variants that provide for relief of HMG-CoA accumulation-induced toxicity. The present invention farther provides methods for identifying agents that reduce intracellular accumulation of HMG-CoA.
    • 本发明提供在遗传修饰的宿主细胞中产生类异戊二烯或类异戊二烯前体的方法。 方法通常涉及调节细胞中羟甲基戊二酰辅酶A(HMG-CoA)的水平,使得HMG-CoA的水平对细胞无毒性和/或基本上不抑制细胞生长,但维持在一个水平 其规定了甲羟戊酸,IPP和类异戊二烯或类异戊二烯途径的其它下游产物的高水平生产,例如聚丙二醇二磷酸和类异戊二烯化合物。 本发明还提供了适用于本发明方法的经遗传修饰的宿主细胞。 本发明还提供用于产生受试者遗传修饰的宿主细胞的重组核酸构建体,包括重组核酸构建体,其包含编码一种或多种甲羟戊酸途径酶的核苷酸序列,以及包含其的重组载体(例如,重组表达载体)。 本发明还提供了用于鉴定编码提供HMG-CoA积累诱导的毒性的HMG-CoA还原酶(HMGR)变体的核酸的方法。 本发明进一步提供用于鉴定减少HMG-CoA的细胞内积累的试剂的方法。